Skip to main content
OpenTrials
Completed

NCT Number: NCT03476265

Lower Esophageal Sphincter (LES) Stimulation in Patients With Ineffective Esophageal Motility

The aim of this study is to evaluate gastroesophageal reflux disease - health related quality of life (GERD-HRQL) after electrical stimulation of the lower esophageal sphincter (LES) in patients with gastroesophageal reflux disease (GERD) and esophageal dysmotility.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Background The growing burden of gastroesophageal reflux disease (GERD) still impacts healthcare costs intensively. Although the treatment with proton pump inhibitor (PPI) is effective in many cases, surgical treatment remains relevant due to a large amount of PPI refractory GERD. Laparoscopic fundoplication (LF) is considered as standard procedure, but this type of surgery is linked to side effects as dysphagia, gas bloating and inability to belch. Especially patients with ineffective esophageal motility (IEM) are prone to postoperative dysphagia after LF. Lower esophageal sphincter electrical stimulation (LES-EST) was introduced as an alternative technique to avoid side effects of LF. Rodriquez et al. have bee demonstrated that LES-EST significantly raises the LES pressure and improved GERD symptoms such as heartburn and regurgitation. The advantage of this procedure is that the anatomy of the esophageal-gastric junction is not altered dramatically. Notably, patients with severely disordered esophageal peristalsis will benefit from this low-risk profile.

After successful implementation of this technique at the Medical University of Vienna (EK 1149/2014), a prospective evaluation of data with the well established gastroesophageal reflux disease - health-related quality of life is next. Patients with esophageal motility disorder, who undergo LES-EST, will be investigated towards side effects such as gas-bloating, inability to belch, flatulence and dysphagia.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is indicated for LES Stimulation and plans to undergo antireflux surgery.
  • Subject is meeting the criteria of IEM (Chicago classification v3.0)
  • Subject provides signed informed consent

Exclusion criteria

  • Subject is within a vulnerable population or is unable to understand the informed consent.
  • Subject is unwilling to attend follow-up visits.

Treatment and study plan

Electrical Stimulation of the Lower Esophageal Sphincter

Device

Laparoscopic implantation of an electrical stimulation device to perform an electrical sphincter augmentation for the treatment of GERD.

Primary outcomes

  1. Change in patient's GERD-HRQL from baseline to 6 months.

    Time frame: 6 months

    GERD related quality of life (QoL) is assessed with the "gastroesophageal reflux disease - health related quality of life" (GERD-HRQL) questionnaire. QoL is measured at baseline and at six months afters surgery. At unscheduled follow up visits QoL assessment is non-compulsory. The GERD-HRQL score consists of ten questions regarding GERD-related symptoms and their influence on QoL. Total scores range from 0 to 75. Testing will be split to a questionnaire for heartburn (0-30) and a questionnaire for regurgitation (0-30), the two cardinal symptoms of GERD. Lower scores indicate better QoL. This questionnaire was designed to objectively quantify symptom severity and was described validated by Velanovich et al and since then is the most frequently used GERD specific questionnaire.

Secondary outcomes

  1. Change of pH-metry from baseline to 6 months follow up

    Time frame: 6 months

    Total % of time of pH < 4 in 24 hours impedance/pH reflux monitoring (ZepHr®, Sandhill Scientific Inc., USA).

  2. Change of number of reflux events >1minute and >5 minute duration from baseline to 6 months follow up

    Time frame: 6 months

    24 hours impedance/pH reflux monitoring (ZepHr®, Sandhill Scientific Inc., USA).

  3. Distal Contractile Integral

    Time frame: 6 months

    High-resolution impedance manometry (InSIGHT Ultima®, Sandhill Scientific Inc., USA)

Sponsors and collaborators

Lead sponsor

Austrian Society Of Surgical Oncology

Other

Registry information

Official study title

Evaluation of Gastroesophageal Reflux Disease - Health Related Quality of Life After Lower Esophageal Sphincter (LES) Stimulation in Patients With Ineffective Esophageal Motilitygus (IEM)

Acronym: DYSMOSTIM

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Mar 26, 2018
Registry last updated
Jul 5, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.